Featured
10 Feb 2026
Sten R. Sörensen, Cereno Scientific 🇸🇪 | Drug Repurposing, Retail Investors on the Flot.bio podcast with Philip Hemme
30 Apr 2026
The Disease-Modification Bet in Pulmonary Arterial Hypertension
Interview with Sten R. Sörensen, CEO, by Moe Alsumidaie, The Clinical Trial Vanguard.
05 Feb 2026
Capital Markets Day 2026
No results found
Try adjusting your search or filter to find what you're looking for.
Date
Title
{{header.label}}